Association between Body Composition and Disease Severity in Patients with Motor Neuron Disease / Amyotrophic Lateral Sclerosis

The change in nutritional status is observed in patients with Motor Neuron Disease, in body composition. The electrical bio impedance method (BIA) determines lean mass, fat mass and phase angle, by estimating total body water. ALSFRS-R is used to monitor the functionality and progression of the disease. Objective: To evaluate the composition with ALSFRS-R. Methodology: Cross-sectional study in adult patients with conclusive diagnosis of MND. For the classification of nutritional status, BMI was used, and for body composition analysis, measurements of lean mass, fat mass, total body water and phase angle. Results: patients, with 54.8% of males with median age of 61.0 years. 77.4% presented the appendicular form of the disease. The median score of ALSFRS-R was 27 points, and the average BMI was 22.6 kg / m2. The phase angle had an average of 3.9 in women, and 4.1 in men. For statistical analysis, results with a probability of type I error lower than 5% (p <0.05 and p <0.001) were considered as statistically significant. The BMI and phase angle were correlated with the scale scores. Conclusion: Nutritional status is directly related to disease progression, and depletion of body compartments influences the functionality of patients with MND.

[1]  C. Gennings,et al.  Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis. , 2016, JAMA neurology.

[2]  P. Corcia,et al.  Nutritional assessment of amyotrophic lateral sclerosis in routine practice: Value of weighing and bioelectrical impedance analysis , 2015, Muscle & nerve.

[3]  A. Ludolph,et al.  High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[4]  A. Chiò,et al.  Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature , 2013, Neuroepidemiology.

[5]  M. Thun,et al.  Premorbid body mass index and risk of amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[6]  D. Levy,et al.  Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[7]  Y. Kuroiwa,et al.  Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[8]  S. Paganoni,et al.  Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis , 2011, Muscle & nerve.

[9]  J. G. Silva,et al.  Amyotrophic lateral sclerosis: one or multiple causes? , 2011, Neurology international.

[10]  J. Kassubek,et al.  Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis , 2011, Journal of Neurology.

[11]  P. Preux,et al.  Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  M. York,et al.  A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[13]  Lucette Lacomblez,et al.  Progression in ALS is not linear but is curvilinear , 2010, Journal of Neurology.

[14]  M. França,et al.  Effect of nutritional supplementation with milk whey proteins in amyotrophic lateral sclerosis patients. , 2010, Arquivos de neuro-psiquiatria.

[15]  V. Meininger,et al.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis , 2008, Neurology.

[16]  P. Preux,et al.  Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[17]  B. Beaufrère,et al.  Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. , 2003, The American journal of clinical nutrition.

[18]  R S Howard,et al.  Management of motor neurone disease , 2002, Postgraduate medical journal.

[19]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[20]  V. Meininger,et al.  Management of amyotrophic lateral sclerosis. , 2008, Drugs.